Given the persistent T cell activation/exhaustion observed in patients who recovered from COVID-19, we aimed to investigate the CD4+ T cell–dependent response following specific or nonspecific in vitro stimulation using an ex vivo IFN-γ–based ELISpot assay. The gene discussed is IFNG; the disease is COVID-19.